{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:15:20Z","timestamp":1780337720380,"version":"3.54.1"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>No fully validated index is available for assessing overall disease activity\nin systemic sclerosis (SSc).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>To estimate the effect of disease activity as measured by different disease activity indices\non the risk of subsequent organ damage.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The European Systemic sclerosis study group activity index (EScSG AI), the European\nScleroderma Trials and Research Group Activity Index (r-EUSTAR AI), 12 point activity index\nproposed by Minier (12point AI) were calculated for 91 patients; the CRISS (The Composite Response\nIndex for Systemic Sclerosis) for patients included after 2016. Data were analysed by parametric\nand non-parametric tests and logistic regression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>EscSG AI, r-EUSTAR AI and 12point AI correlated with lung involvement. EScSG AI\nand r-EUSTAR AI correlated with diffuse skin involvement. EscSG AI correlated with digital ulcers\nand diffuse cutaneous involvement and r-EUSTAR AI with a renal crisis.\nBivariate analysis showed an inverse correlation between the three disease activity scores and\nforced vital capacity (FVC) (p&lt;0.001) and diffusing capacity for carbon monoxide (DLCO)\n(p&lt;0.001) and positive correlation with pulmonary fibrosis (p&lt;0.001), modified Rodnan skin score\n(mRSS) (p&lt;0.001), health assessment questionnaire (HAQ) (p&lt;0.001), systolic pulmonary pressure\n(sPAP) (p&lt;0.001), C-reactive protein (CRP) (p&lt;0.001) and capillaroscopy scoring (p&lt;0.001) at\nboth baseline visit and the 3-year follow-up visit. Logistic regression revealed that baseline EScSG\nAI adjusted for gender and age and that baseline 12-point AI both adjusted and unadjusted predicted\nworse skin involvement at 3-year follow-up; while adjusted EScSG AI predicted decreasing DLCO.\nAlso, 12-point AI predicted a decline of FVC and higher HAQ scores at 3-year follow up;\nwhile baseline r-EUSTAR AI was able to predict muscular deterioration, decline of FVC and the increase\nof HAQ score during 3 years of following. An active disease according to EScSG AI at first\nvisit predicted progression of joint involvement while an active disease at baseline showed by r-\nEUSTAR AI predicted muscular deterioration, FVC and DLCO worsening, as well as an increase\nin HAQ score during the follow-up period. r-EUSTAR AI was the only score to predict the decrease\nof FVC in a multiple regression prediction model (OR= 1.306 (1.025, 1.665), p=0.31) while\nbaseline EScSG AI best predicted worsening of DLCO (OR=1.749 (1.104, 2.772), p=0.017).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our study could not establish a gold standard to assess disease activity in SSc; especially\nEscSG AI and r-EUSTAR AI could quantify and predict major organ involvement in daily\npractice. CRISS can be useful as an outcome measure for patients with short disease duration included\nin clinical studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397117666210913102759","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:06:11Z","timestamp":1631775971000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Do We Have Good Activity Indices in Systemic Sclerosis?"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-1199","authenticated-orcid":true,"given":"Laura","family":"Groseanu","sequence":"first","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorana","family":"Petrescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra","family":"Balanescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Bojinca","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Opris-Belinski","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Berghea","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mazilu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Saulescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Borangiu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanziana","family":"Daia-Iliescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cobilinschi","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Abobului","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Magdalena","family":"Negru","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania | Sfanta Maria Clinical Hospital,\nBucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"S3","volume":"33","author":"Barsotti S.","year":"2015","unstructured":"Barsotti S.; Stagnaro C.; Della Rossa A.; Systemic sclerosis: a critical digest of the recent literature. Clin Exp Rheumatol 2015,33(4)(Suppl. 91),S3-S14","journal-title":"Clin Exp Rheumatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"Medsger T.A.","year":"2003","unstructured":"Medsger T.A.; Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003,29(2),255-273, vi","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=3","first-page":"186","volume":"34","author":"Melsens K","year":"2016","unstructured":"Melsens K; De Keyser F; Decuman S; Piette Y; Vandecasteele E; Smith V; Disease activity indices in systemic sclerosis: a systematic literature review. Clin Exp Rheumatol 2016,34(5),186-192","journal-title":"Clin Exp Rheumatol"},{"key":"ref=4","first-page":"1194","volume":"34","author":"Furst D.","year":"2007","unstructured":"Furst D.; Khanna D.; Matucci-Cerinic M.; Clements P.; Steen V.; Pope J.; Merkel P.; Foeldvari I.; Seibold J.; Pittrow D.; Polisson R.; Strand V.; Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol 2007,34(5),1194-1200","journal-title":"J Rheumatol"},{"key":"ref=5","first-page":"1630","volume":"30","author":"Merkel P.A.","year":"2003","unstructured":"Merkel P.A.; Clements P.J.; Reveille J.D.; Suarez-Almazor M.E.; Valentini G.; Furst D.E.; Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003,30(7),1630-1647","journal-title":"J Rheumatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/ken269","volume":"47","author":"Furst D.E.","year":"2008","unstructured":"Furst D.E.; Outcome measures in rheumatologic clinical trials and systemic sclerosis. Rheumatology (Oxford) 2008,47(Suppl. 5),v29-v30","journal-title":"Rheumatology (Oxford)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2397198318765061","volume":"3","author":"Ross L.","year":"2018","unstructured":"Ross L.; Baron M.; Nikpour M.; The challenges and controversies of measuring disease activity in systemic sclerosis. J Scleroderma Relat Disord 2018,3(2),115-121","journal-title":"J Scleroderma Relat Disord"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"Valentini G.","year":"2001","unstructured":"Valentini G.; Della Rossa A.; Bombardieri S.; Bencivelli W.; Silman A.J.; D\u2019Angelo S.; Cerinic M.M.; Belch J.F.; Black C.M.; Bruhlmann P.; Czirj\u00e1k L.; De Luca A.; Drosos A.A.; Ferri C.; Gabrielli A.; Giacomelli R.; Hayem G.; Inanc M.; McHugh N.J.; Nielsen H.; Rosada M.; Scorza R.; Stork J.; Sysa A.; van den Hoogen F.H.; Vlachoyiannopoulos P.J.; European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001,60(6),592-598","journal-title":"Ann Rheum Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","volume":"49","author":"Minier T.","year":"2010","unstructured":"Minier T.; Nagy Z.; B\u00e1lint Z.; Farkas H.; Radics J.; Kum\u00e1novics G.; Cz\u00f6mp\u00f6ly T.; Simon D.; Varj\u00fa C.; N\u00e9meth P.; Czirj\u00e1k L.; Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis. Rheumatology (Oxford) 2010,49(6),1133-1145","journal-title":"Rheumatology (Oxford)"},{"key":"ref=10","first-page":"270","volume":"76","author":"Valentini G","year":"2017","unstructured":"Valentini G; Iudici M; Walker UA; The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexAnnals of the Rheumatic Diseases. 2017,76,270-276"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/art.39501","volume":"68","author":"Khanna D.","year":"2016","unstructured":"Khanna D.; Berrocal V.J.; Giannini E.H.; Seibold J.R.; Merkel P.A.; Mayes M.D.; Baron M.; Clements P.J.; Steen V.; Assassi S.; Schiopu E.; Phillips K.; Simms R.W.; Allanore Y.; Denton C.P.; Distler O.; Johnson S.R.; Matucci-Cerinic M.; Pope J.E.; Proudman S.M.; Siegel J.; Wong W.K.; Wells A.U.; Furst D.E.; The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol 2016,68(2),299-311","journal-title":"Arthritis Rheumatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/ard.2007.079756","volume":"67","author":"Sulli A.","year":"2008","unstructured":"Sulli A.; Secchi M.E.; Pizzorni C.; Cutolo M.; Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008,67(6),885-887","journal-title":"Ann Rheum Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"Penn H.","year":"2007","unstructured":"Penn H.; Howie A.J.; Kingdon E.J.; Bunn C.C.; Stratton R.J.; Black C.M.; Burns A.; Denton C.P.; Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007,100(8),485-494","journal-title":"QJM"},{"key":"ref=14","first-page":"2159","volume":"26","author":"Medsger T.A.","year":"1999","unstructured":"Medsger T.A.; Silman A.J.; Steen V.D.; Black C.M.; Akesson A.; Bacon P.A.; Harris C.A.; Jablonska S.; Jayson M.I.; Jimenez S.A.; Krieg T.; Leroy E.C.; Maddison P.J.; Russell M.L.; Schachter R.K.; Wollheim F.A.; Zacharaie H.; A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999,26(10),2159-2167","journal-title":"J Rheumatol"},{"key":"ref=15","author":"Tabachnick B.G.","year":"2001","unstructured":"Tabachnick B.G.; Fidell L.S.;  Using multivariate statistics 2001","journal-title":"Using multivariate statistics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/rheumatology\/kex015","volume":"56","author":"Nevskaya T.","year":"2017","unstructured":"Nevskaya T.; Baron M.; Pope J.E.; Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Rheumatology (Oxford) 2017,56(7),1111-1122","journal-title":"Rheumatology (Oxford)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/annrheumdis-2019-215787","volume":"78","author":"Fasano S.","year":"2019","unstructured":"Fasano S.; Riccardi A.; Messiniti V.; Caramaschi P.; Rosato E.; Maurer B.; Smith V.; Siegert E.; De Langhe E.; Riccieri V.; Air\u00f3 P.; Mihai C.; Avouac J.; Zanatta E.; Walker U.A.; Iannone F.; Garc\u00eda De la Pe\u00f1a Lefebvre P.; Distler J.H.W.; Vacca A.; Distler O.; Kowal-Bielecka O.; Allanore Y.; Valentini G.; Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual. Ann Rheum Dis 2019,78(12),1681-1685","journal-title":"Ann Rheum Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/14397595.2018.1551265","volume":"29","author":"Horimoto A.M.C.","year":"2019","unstructured":"Horimoto A.M.C.; Camargo C.Z.; Kayser C.; Less severe disease in patients with early systemic sclerosis? Mod Rheumatol 2019,29(6),977-983","journal-title":"Mod Rheumatol"},{"key":"ref=19","first-page":"1565","volume":"78","author":"Ovsyannikova O.","year":"2019","unstructured":"Ovsyannikova O.; Ananyeva L.P.; Koneva O.; Association of European Scleroderma Study Group Activity Index (EScSG-AI) with progression pulmonary alterations by HRCT in patients with systemic sclerosis over a five year period. Ann Rheum Dis 2019,78,1565-1566","journal-title":"Ann Rheum Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.rdc.2007.11.005","volume":"34","author":"Nihtyanova S.I.","year":"2008","unstructured":"Nihtyanova S.I.; Denton C.P.; Current approaches to the management of early active diffuse scleroderma skin disease. Rheum Dis Clin North Am 2008,34(1),161-179, viii","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/art.24681","volume":"60","author":"Amjadi S.","year":"2009","unstructured":"Amjadi S.; Maranian P.; Furst D.E.; Clements P.J.; Wong W.K.; Postlethwaite A.E.; Khanna P.P.; Khanna D.; Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 2009,60(8),2490-2498","journal-title":"Arthritis Rheum"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.24676","volume":"61","author":"Hudson M.","year":"2009","unstructured":"Hudson M.; Thombs B.D.; Steele R.; Panopalis P.; Newton E.; Baron M.; Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009,61(8),1112-1120","journal-title":"Arthritis Rheum"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3899\/jrheum.080281","volume":"36","author":"Hudson M.","year":"2009","unstructured":"Hudson M.; Thombs B.D.; Steele R.; Panopalis P.; Newton E.; Baron M.; Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 2009,36(4),768-772","journal-title":"J Rheumatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-019-1842-x","volume":"21","author":"Park E.H.","year":"2019","unstructured":"Park E.H.; Strand V.; Oh Y.J.; Song Y.W.; Lee E.B.; Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019,21(1),61","journal-title":"Arthritis Res Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10067-014-2525-2","volume":"33","author":"Chan P.T.","year":"2014","unstructured":"Chan P.T.; Mok C.C.; Chan K.L.; Ho L.Y.; Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study. Clin Rheumatol 2014,33(5),659-666","journal-title":"Clin Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666210913102759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/196405\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666210913102759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:24:19Z","timestamp":1656581059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/196405\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397117666210913102759","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}